Detalhe da pesquisa
1.
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence.
J Med Virol
; 94(2): 491-498, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002743
2.
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
Cancer Immunol Immunother
; 70(6): 1667-1678, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315149
3.
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel.
Pharmacogenomics J
; 21(2): 233-242, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462346
4.
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.
Breast Cancer Res Treat
; 178(1): 57-62, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346846
5.
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells.
Stem Cells
; 36(5): 633-640, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29352734
6.
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report.
BMC Cancer
; 19(1): 410, 2019 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039766
7.
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer.
BJU Int
; 124(4): 693-700, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055861
8.
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response.
Br J Cancer
; 119(10): 1252-1258, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30397287
9.
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.
Br J Cancer
; 118(6): 820-824, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509748
10.
Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer.
Cancers (Basel)
; 13(15)2021 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359638
11.
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer.
Front Oncol
; 10: 593831, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33489892
12.
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers.
Crit Rev Oncol Hematol
; 154: 102891, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32340783
13.
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.
Clin Lung Cancer
; 21(3): 232-237, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31735523
14.
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy.
Cancer Chemother Pharmacol
; 84(6): 1219-1227, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529205
15.
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer.
Pharmacogenomics
; 20(1): 49-68, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520336
16.
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers.
Crit Rev Oncol Hematol
; 144: 102812, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698313
17.
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC.
Lung Cancer
; 131: 78-85, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31027702
18.
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial.
JAMA Oncol
; 5(3): 343-350, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476968
19.
Clinical pharmacology of intravitreal anti-VEGF drugs.
Eye (Lond)
; 32(6): 1010-1020, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29398697
20.
EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance.
Pharmacogenomics
; 19(8): 727-740, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785875